Company Info
Phone(608) 291-0574
Year Established
2012
Contacts
Richard Lesniewski, Ph.D.Co-Founder, President & CEOTodd Argall
Douglas McNeel, MD, PhD
CSO, CMO & Co-Founder
Company Description
MVI is developing DNA vaccines intended to treat prostate cancer at crucial stages in the disease.